Lannett Co Inc Expected to Earn Q1 2018 Earnings of $0.52 Per Share (LCI)
Lannett Co Inc (NYSE:LCI) – Equities researchers at Oppenheimer Holdings dropped their Q1 2018 EPS estimates for Lannett Co in a research note issued on Monday. Oppenheimer Holdings analyst D. Archila now forecasts that the company will earn $0.52 per share for the quarter, down from their previous estimate of $0.53. Oppenheimer Holdings currently has a “Hold” rating on the stock. Oppenheimer Holdings also issued estimates for Lannett Co’s Q2 2018 earnings at $0.68 EPS, Q3 2018 earnings at $0.80 EPS, Q4 2018 earnings at $0.90 EPS, FY2019 earnings at $3.11 EPS and FY2020 earnings at $2.96 EPS.
Lannett Co (NYSE:LCI) last released its earnings results on Wednesday, August 23rd. The company reported $0.40 EPS for the quarter, meeting analysts’ consensus estimates of $0.40. Lannett Co had a positive return on equity of 19.80% and a negative net margin of 0.09%. The company had revenue of $139.10 million during the quarter, compared to the consensus estimate of $139.01 million. During the same quarter last year, the company earned $0.73 earnings per share. Lannett Co’s quarterly revenue was down 17.6% compared to the same quarter last year. ILLEGAL ACTIVITY WARNING: “Lannett Co Inc Expected to Earn Q1 2018 Earnings of $0.52 Per Share (LCI)” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/10/11/lannett-co-inc-expected-to-earn-q1-2018-earnings-of-0-52-per-share-lci.html.
A number of other research analysts have also issued reports on the company. ValuEngine upgraded Lannett Co from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Zacks Investment Research lowered Lannett Co from a “hold” rating to a “strong sell” rating in a research report on Tuesday, September 12th. BMO Capital Markets reiterated a “market perform” rating and set a $20.00 price target (down previously from $26.00) on shares of Lannett Co in a research report on Thursday, August 24th. Roth Capital set a $27.00 price target on Lannett Co and gave the stock a “buy” rating in a research report on Tuesday, August 22nd. Finally, Deutsche Bank AG reduced their price target on Lannett Co from $23.00 to $19.00 and set a “hold” rating for the company in a research report on Monday, August 14th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $21.80.
Lannett Co (NYSE LCI) traded down 0.95% during midday trading on Wednesday, reaching $20.85. The company’s stock had a trading volume of 20,306 shares. The company’s market capitalization is $777.37 million. The company’s 50-day moving average price is $18.00 and its 200-day moving average price is $20.18. Lannett Co has a 1-year low of $14.90 and a 1-year high of $27.90.
Several institutional investors have recently made changes to their positions in LCI. Great West Life Assurance Co. Can lifted its holdings in shares of Lannett Co by 5.8% in the first quarter. Great West Life Assurance Co. Can now owns 40,254 shares of the company’s stock valued at $898,000 after buying an additional 2,212 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Lannett Co by 3.4% in the first quarter. Bank of New York Mellon Corp now owns 383,309 shares of the company’s stock valued at $8,568,000 after buying an additional 12,745 shares during the period. Comerica Bank lifted its holdings in shares of Lannett Co by 4.8% in the first quarter. Comerica Bank now owns 32,665 shares of the company’s stock valued at $848,000 after buying an additional 1,485 shares during the period. Swiss National Bank lifted its holdings in shares of Lannett Co by 3.8% in the first quarter. Swiss National Bank now owns 48,800 shares of the company’s stock valued at $1,091,000 after buying an additional 1,800 shares during the period. Finally, State of Tennessee Treasury Department lifted its holdings in shares of Lannett Co by 17.8% in the first quarter. State of Tennessee Treasury Department now owns 26,053 shares of the company’s stock valued at $582,000 after buying an additional 3,932 shares during the period. Institutional investors and hedge funds own 87.92% of the company’s stock.
Lannett Co Company Profile
Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.
Receive News & Ratings for Lannett Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Co Inc and related companies with MarketBeat.com's FREE daily email newsletter.